ALGN
ALIGN TECHNOLOGY INC
NASDAQ · Healthcare · Medical - Devices · US
$149.00
+1.15%Year over year
Reported trailing growth
- Revenue
- +4.4%
- EBITDA
- -2.2%
- EBIT
- -8.1%
- EPS
- -2.9%
- Free cash flow
- +11.4%
- Operating cash flow
- +3.4%
Forward estimates
Based on analyst estimates
- Revenue
- +2.5%
- EBITDA
- +64.2%
- EPS
- +109.7%
Three-year CAGR
- Revenue
- +2.6%
- EBITDA
- +1.8%
- EBIT
- -1.4%
- Net income
- +4.3%
- EPS
- +7.0%
- Free cash flow
- +21.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026